Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)

Study Questions:

What is the safety and efficacy of N-acetylcysteine (NAC) for prevention of contrast-induced nephropathy (CIN)?